GOVX GeoVax Labs Inc

Price (delayed)

$1.74

Market cap

$4.02M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$14.51

Enterprise value

$3.25M

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On ...

Highlights
The equity has dropped by 100% year-on-year and by 99% since the previous quarter
The quick ratio has plunged by 96% YoY and by 87% from the previous quarter

Key stats

What are the main financial stats of GOVX
Market
Shares outstanding
2.31M
Market cap
$4.02M
Enterprise value
$3.25M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
69.64
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$27.78M
EBITDA
-$27.7M
Free cash flow
-$27.14M
Per share
EPS
-$14.51
Free cash flow per share
-$11.47
Book value per share
$0.02
Revenue per share
$0
TBVPS
$1.42
Balance sheet
Total assets
$3.36M
Total liabilities
$3.3M
Debt
$0
Equity
$54,275
Working capital
-$441,529
Liquidity
Debt to equity
0
Current ratio
0.87
Quick ratio
0.23
Net debt/EBITDA
0.03
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-221.8%
Return on equity
-346.2%
Return on invested capital
N/A
Return on capital employed
-51,181.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GOVX stock price

How has the GeoVax Labs stock price performed over time
Intraday
2.96%
1 week
2.35%
1 month
12.99%
1 year
132%
YTD
381.99%
QTD
-13%

Financial performance

How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$28.36M
Net income
-$27.78M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 79% YoY and by 6% from the previous quarter
GeoVax Labs's net income has plunged by 78% YoY and by 7% from the previous quarter

Growth

What is GeoVax Labs's growth rate over time

Valuation

What is GeoVax Labs stock price valuation
P/E
N/A
P/B
69.64
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 38% year-on-year
The equity has dropped by 100% year-on-year and by 99% since the previous quarter

Efficiency

How efficient is GeoVax Labs business performance
The return on equity has dropped by 83% since the previous quarter
The ROA has dropped by 58% since the previous quarter

Dividends

What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOVX.

Financial health

How did GeoVax Labs financials performed over time
The quick ratio has plunged by 96% YoY and by 87% from the previous quarter
GOVX's total assets has plunged by 88% YoY and by 64% from the previous quarter
The debt is 100% smaller than the equity
The equity has dropped by 100% year-on-year and by 99% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.